Studienserver - Medizinische Hochschule Hannover

Studien: InductionChemo-Radio-Antibody-Treatment

ID Studie

ICRAT

EudraCT-Nummer

2010-019347-18

Clinicaltrials.gov Identifier

NCT01181401

Beschreibung

Randomized Phase II Study of two different protocols of TPF induction chemotherapy regimen followed by radiation therapy plus Cetuximab (TPF-HART-CET) vs. HART plus Cisplatinum (CIS-HART) in patients with locally advanced unresectable squamous cell carcinomas of the head and neck

Status

aktiv